Birdwatch Note
2023-04-29 11:07:26 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Antineoplastons are an experimental treatment explored since the 1970s, but have never been proven to be an effective cancer therapy. No large-scale trials of antineoplastons have been conducted & no randomized or controlled trials comparing the drugs have been performed, https://www.reuters.com/article/factcheck-antineoplaston-burzynski-cance-idUSL1N34O1TN
Written by 901B60EACFF5B854C30EF94EAEEE7B0281F2CA142B307A0E657F2EA42AA24955
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1652202276759691264
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1652268349999464449
- noteId - 1652268349999464449
- participantId -
- noteAuthorParticipantId - 901B60EACFF5B854C30EF94EAEEE7B0281F2CA142B307A0E657F2EA42AA24955 Participant Details
- createdAtMillis - 1682766446958
- tweetId - 1652202276759691264
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Antineoplastons are an experimental treatment explored since the 1970s, but have never been proven to be an effective cancer therapy. No large-scale trials of antineoplastons have been conducted & no randomized or controlled trials comparing the drugs have been performed, https://www.reuters.com/article/factcheck-antineoplaston-burzynski-cance-idUSL1N34O1TN
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-04-29 11:07:26 UTC (1682766446958) |
2023-04-29 19:42:30 UTC (1682797350982) |
CURRENTLY_RATED_HELPFUL | 2023-05-06 02:42:24 UTC (1683340944665) |
CURRENTLY_RATED_HELPFUL | 2023-04-29 19:42:30 UTC (1682797350982) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2023-05-02 18:31:19 -0500 | Rating Details | |
| 2023-05-02 18:27:28 -0500 | Rating Details | |
| 2023-04-30 21:04:42 -0500 | Rating Details | |
| 2023-04-30 15:17:12 -0500 | Rating Details | |
| 2023-04-30 11:43:03 -0500 | Rating Details | |
| 2023-04-30 11:18:42 -0500 | Rating Details | |
| 2023-04-30 07:25:25 -0500 | Rating Details | |
| 2023-04-30 06:36:50 -0500 | Rating Details | |
| 2023-04-30 01:16:31 -0500 | Rating Details | |
| 2023-04-30 00:32:32 -0500 | Rating Details | |
| 2023-04-30 00:32:04 -0500 | Rating Details | |
| 2023-04-30 00:13:31 -0500 | Rating Details | |
| 2023-04-29 23:48:40 -0500 | Rating Details | |
| 2023-04-29 23:38:42 -0500 | Rating Details | |
| 2023-04-29 23:28:27 -0500 | Rating Details | |
| 2023-04-29 23:09:31 -0500 | Rating Details | |
| 2023-04-29 23:01:18 -0500 | Rating Details | |
| 2023-04-29 22:58:57 -0500 | Rating Details | |
| 2023-04-29 22:11:04 -0500 | Rating Details | |
| 2023-04-29 20:28:37 -0500 | Rating Details | |
| 2023-04-29 20:24:48 -0500 | Rating Details | |
| 2023-04-29 20:19:55 -0500 | Rating Details | |
| 2023-04-29 20:07:41 -0500 | Rating Details | |
| 2023-04-29 19:55:37 -0500 | Rating Details | |
| 2023-04-29 19:53:33 -0500 | Rating Details | |
| 2023-04-29 19:48:39 -0500 | Rating Details | |
| 2023-04-29 19:44:04 -0500 | Rating Details | |
| 2023-04-29 19:39:31 -0500 | Rating Details | |
| 2023-04-29 19:11:02 -0500 | Rating Details | |
| 2023-04-29 19:10:45 -0500 | Rating Details | |
| 2023-04-29 19:09:03 -0500 | Rating Details | |
| 2023-04-29 19:08:50 -0500 | Rating Details | |
| 2023-04-29 19:08:01 -0500 | Rating Details | |
| 2023-04-29 17:18:33 -0500 | Rating Details | |
| 2023-04-29 16:44:36 -0500 | Rating Details | |
| 2023-04-29 16:13:45 -0500 | Rating Details | |
| 2023-04-29 16:11:04 -0500 | Rating Details | |
| 2023-04-29 16:09:26 -0500 | Rating Details | |
| 2023-04-29 16:04:17 -0500 | Rating Details | |
| 2023-04-29 15:26:16 -0500 | Rating Details | |
| 2023-04-29 14:57:58 -0500 | Rating Details | |
| 2023-04-29 14:05:13 -0500 | Rating Details | |
| 2023-04-29 13:37:56 -0500 | Rating Details | |
| 2023-04-29 13:35:01 -0500 | Rating Details | |
| 2023-04-29 13:23:58 -0500 | Rating Details | |
| 2023-04-29 13:18:27 -0500 | Rating Details | |
| 2023-04-29 13:17:55 -0500 | Rating Details | |
| 2023-04-29 12:51:08 -0500 | Rating Details | |
| 2023-04-29 12:49:35 -0500 | Rating Details | |
| 2023-04-29 12:49:21 -0500 | Rating Details | |
| 2023-04-29 12:37:55 -0500 | Rating Details | |
| 2023-04-29 12:13:55 -0500 | Rating Details | |
| 2023-04-29 12:06:00 -0500 | Rating Details | |
| 2023-04-29 12:03:42 -0500 | Rating Details | |
| 2023-04-29 12:00:39 -0500 | Rating Details | |
| 2023-04-29 11:53:15 -0500 | Rating Details | |
| 2023-04-29 11:52:08 -0500 | Rating Details | |
| 2023-04-29 11:47:50 -0500 | Rating Details | |
| 2023-04-29 11:43:58 -0500 | Rating Details | |
| 2023-04-29 11:42:57 -0500 | Rating Details | |
| 2023-04-29 11:41:58 -0500 | Rating Details | |
| 2023-04-29 11:36:38 -0500 | Rating Details | |
| 2023-04-29 11:33:51 -0500 | Rating Details | |
| 2023-04-29 11:31:55 -0500 | Rating Details | |
| 2023-04-29 11:27:05 -0500 | Rating Details | |
| 2023-04-29 11:26:45 -0500 | Rating Details | |
| 2023-04-29 11:26:13 -0500 | Rating Details | |
| 2023-04-29 11:21:10 -0500 | Rating Details | |
| 2023-04-29 11:14:25 -0500 | Rating Details | |
| 2023-04-29 11:14:10 -0500 | Rating Details | |
| 2023-04-29 11:12:59 -0500 | Rating Details | |
| 2023-04-29 11:10:19 -0500 | Rating Details | |
| 2023-04-29 11:08:14 -0500 | Rating Details | |
| 2023-04-29 11:04:38 -0500 | Rating Details | |
| 2023-04-29 10:52:56 -0500 | Rating Details | |
| 2023-04-29 10:50:40 -0500 | Rating Details | |
| 2023-04-29 10:41:51 -0500 | Rating Details | |
| 2023-04-29 09:21:55 -0500 | Rating Details | |
| 2023-04-29 08:34:03 -0500 | Rating Details | |
| 2023-04-29 08:04:54 -0500 | Rating Details | |
| 2023-04-29 08:01:54 -0500 | Rating Details | |
| 2023-04-29 07:32:51 -0500 | Rating Details | |
| 2023-04-29 07:23:01 -0500 | Rating Details | |
| 2023-04-29 07:17:40 -0500 | Rating Details | |
| 2023-04-29 06:41:05 -0500 | Rating Details | |
| 2023-04-29 06:31:18 -0500 | Rating Details | |
| 2023-04-29 06:28:31 -0500 | Rating Details | |
| 2023-04-29 06:21:53 -0500 | Rating Details | |
| 2023-04-29 06:14:13 -0500 | Rating Details | |
| 2023-04-29 06:09:58 -0500 | Rating Details | |
| 2023-05-02 18:31:19 -0500 | Rating Details | |
| 2023-04-29 11:41:58 -0500 | Rating Details | |
| 2023-04-29 08:34:03 -0500 | Rating Details | |
| 2023-04-29 13:17:55 -0500 | Rating Details | |
| 2023-04-29 16:11:04 -0500 | Rating Details | |
| 2023-04-29 19:55:37 -0500 | Rating Details | |
| 2023-04-29 20:19:55 -0500 | Rating Details | |
| 2023-04-29 19:10:45 -0500 | Rating Details | |
| 2023-04-29 14:05:13 -0500 | Rating Details | |
| 2023-04-29 11:26:45 -0500 | Rating Details | |
| 2023-04-29 23:28:27 -0500 | Rating Details | |
| 2023-04-29 11:04:38 -0500 | Rating Details | |
| 2023-04-29 17:18:33 -0500 | Rating Details | |
| 2023-04-29 13:37:56 -0500 | Rating Details | |
| 2023-04-29 11:36:38 -0500 | Rating Details | |
| 2023-04-29 12:49:21 -0500 | Rating Details | |
| 2023-04-29 10:41:51 -0500 | Rating Details | |
| 2023-04-29 11:12:59 -0500 | Rating Details | |
| 2023-04-29 11:10:19 -0500 | Rating Details | |
| 2023-04-29 13:18:27 -0500 | Rating Details | |
| 2023-04-29 12:06:00 -0500 | Rating Details | |
| 2023-04-29 10:50:40 -0500 | Rating Details | |
| 2023-04-29 20:28:37 -0500 | Rating Details | |
| 2023-04-29 11:42:57 -0500 | Rating Details | |
| 2023-04-29 11:43:58 -0500 | Rating Details | |
| 2023-04-29 23:48:40 -0500 | Rating Details | |
| 2023-04-29 19:09:03 -0500 | Rating Details | |
| 2023-04-29 23:01:18 -0500 | Rating Details | |
| 2023-04-29 06:41:05 -0500 | Rating Details | |
| 2023-04-29 11:26:13 -0500 | Rating Details | |
| 2023-04-29 10:52:56 -0500 | Rating Details | |
| 2023-04-29 12:49:35 -0500 | Rating Details | |
| 2023-04-29 19:53:33 -0500 | Rating Details | |
| 2023-04-30 11:18:42 -0500 | Rating Details | |
| 2023-04-29 19:44:04 -0500 | Rating Details | |
| 2023-05-02 18:27:28 -0500 | Rating Details | |
| 2023-04-29 09:21:55 -0500 | Rating Details | |
| 2023-04-29 16:04:17 -0500 | Rating Details | |
| 2023-04-29 07:17:40 -0500 | Rating Details | |
| 2023-04-29 12:51:08 -0500 | Rating Details | |
| 2023-04-29 19:08:01 -0500 | Rating Details | |
| 2023-04-29 11:14:25 -0500 | Rating Details | |
| 2023-04-29 22:11:04 -0500 | Rating Details | |
| 2023-04-29 15:26:16 -0500 | Rating Details | |
| 2023-04-29 11:53:15 -0500 | Rating Details | |
| 2023-04-29 06:14:13 -0500 | Rating Details | |
| 2023-04-29 11:27:05 -0500 | Rating Details | |
| 2023-04-29 12:13:55 -0500 | Rating Details | |
| 2023-04-29 19:08:50 -0500 | Rating Details | |
| 2023-04-29 11:33:51 -0500 | Rating Details | |
| 2023-04-29 06:31:18 -0500 | Rating Details | |
| 2023-04-29 11:21:10 -0500 | Rating Details | |
| 2023-04-30 07:25:25 -0500 | Rating Details | |
| 2023-04-29 20:07:41 -0500 | Rating Details | |
| 2023-04-30 01:16:31 -0500 | Rating Details | |
| 2023-04-29 19:11:02 -0500 | Rating Details | |
| 2023-04-29 06:28:31 -0500 | Rating Details | |
| 2023-04-30 11:43:03 -0500 | Rating Details | |
| 2023-04-30 15:17:12 -0500 | Rating Details | |
| 2023-04-30 21:04:42 -0500 | Rating Details | |
| 2023-04-29 19:48:39 -0500 | Rating Details | |
| 2023-04-29 07:32:51 -0500 | Rating Details | |
| 2023-04-29 23:09:31 -0500 | Rating Details | |
| 2023-04-29 12:37:55 -0500 | Rating Details | |
| 2023-04-30 00:32:32 -0500 | Rating Details | |
| 2023-04-29 19:39:31 -0500 | Rating Details | |
| 2023-04-29 11:31:55 -0500 | Rating Details | |
| 2023-04-29 16:13:45 -0500 | Rating Details | |
| 2023-04-29 12:03:42 -0500 | Rating Details | |
| 2023-04-29 12:00:39 -0500 | Rating Details | |
| 2023-04-29 11:47:50 -0500 | Rating Details | |
| 2023-04-29 14:57:58 -0500 | Rating Details | |
| 2023-04-29 11:52:08 -0500 | Rating Details | |
| 2023-04-29 11:14:10 -0500 | Rating Details | |
| 2023-04-29 11:08:14 -0500 | Rating Details | |
| 2023-04-29 06:09:58 -0500 | Rating Details | |
| 2023-04-29 13:23:58 -0500 | Rating Details | |
| 2023-04-29 13:35:01 -0500 | Rating Details | |
| 2023-04-29 06:21:53 -0500 | Rating Details | |
| 2023-04-29 07:23:01 -0500 | Rating Details | |
| 2023-04-29 08:04:54 -0500 | Rating Details | |
| 2023-04-30 00:32:04 -0500 | Rating Details | |
| 2023-04-30 00:13:31 -0500 | Rating Details | |
| 2023-04-30 06:36:50 -0500 | Rating Details | |
| 2023-04-29 08:01:54 -0500 | Rating Details | |
| 2023-04-29 16:44:36 -0500 | Rating Details | |
| 2023-04-29 23:38:42 -0500 | Rating Details | |
| 2023-04-29 20:24:48 -0500 | Rating Details | |
| 2023-04-29 22:58:57 -0500 | Rating Details | |
| 2023-04-29 16:09:26 -0500 | Rating Details | |
| 2023-04-30 01:53:27 -0500 | Rating Details |